New England Capital Financial Advisors LLC Abbott Laboratories Transaction History
New England Capital Financial Advisors LLC
- $197 Billion
- Q1 2025
A detailed history of New England Capital Financial Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, New England Capital Financial Advisors LLC holds 461 shares of ABT stock, worth $62,488. This represents 0.03% of its overall portfolio holdings.
Number of Shares
461
Previous 461
-0.0%
Holding current value
$62,488
Previous $52.2 Million
17.31%
% of portfolio
0.03%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding ABT
# of Institutions
3,533Shares Held
1.38BCall Options Held
9.75MPut Options Held
8.87M-
Vanguard Group Inc Valley Forge, PA170MShares$23 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.8 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.7MShares$10.5 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA66.8MShares$9.06 Billion1.82% of portfolio
-
Capital Research Global Investors Los Angeles, CA50.7MShares$6.88 Billion1.53% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $237B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...